IJCRAR is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCRAR Articles.

INDEXED IN INDEX COPERNICUS - ICI Journals Master List 2016 - IJCRAR--ICV 2016: 81.15 For more details click here

Abstract            Volume:14  Issue-7  Year-2026         Original Research Articles


Online ISSN : 2347 - 3215
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcret@gmail.com

Insitu Gel Systems: A Novel Drug Delivery Strategy
Mahalaxmi Muskan*, Kamal Nayan, Obed Singh and Amit Semwal
College of Pharmacy, Shivalik Campus, Shiniwala, Dehradun, India
*Corresponding author
Abstract:

Conventional liquid and semisolid dosage forms applied to mucosal or periocular surfaces are frequently limited by short residence time, rapid clearance, and poor site specificity, which together reduce bioavailability. In situ gel systems address these limitations by remaining as free-flowing, easily administered solutions that undergo a sol-to-gel phase transition on contact with the physiological environment, triggered by temperature, pH, ionic strength, or specific chemical interactions. Once gelled, the resulting matrix forms a depot at the site of application that prolongs drug residence and supports sustained, controlled release. This property makes the approach particularly valuable for ophthalmic, nasal, oral, vaginal, rectal, and parenteral formulations, where it improves patient compliance by reducing dosing frequency compared with conventional drops, solutions, or injections. This review summarises the principal sol-gel transition mechanisms (thermosensitive, pH-sensitive, ion-activated, and enzyme/redox-responsive systems), the natural and synthetic polymers used to engineer them, and the Quality by Design and Design of Experiments approaches increasingly applied to optimise gelation behaviour and drug release. It further examines regulatory expectations, safety and biocompatibility requirements, manufacturing and scale-up challenges, and the comparative performance of in situ gels against tablets, ointments, and injections. Representative marketed products and preclinical/clinical evidence are discussed by administration route, and emerging directions in nanotechnology-enabled, personalised, and artificial-intelligence-assisted formulation design are outlined. Overall, the availability of a biocompatible, appropriately triggered polymer system remains the central determinant of successful in situ gel development.

Keywords: Insitu gel; sol-gel transition; polymer; bioavailability; ophthalmic drug delivery; sustained release; Quality by Design
Download this article as Download

How to cite this article:

Mahalaxmi Muskan, Kamal Nayan, Obed Singh and Amit Semwal. 2026. In Situ Gel Systems: A Novel Drug Delivery Strategy.Int.J.Curr.Res.Aca.Rev. 14(7): 118-133
doi: https://doi.org/10.20546/ijcrar.2026.1407.011
Copyright: This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike license.